Compare Adaptive Biotechnologies Corp (ADPT) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs 10X Genomics Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: 10X Genomics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ADPT | TXG | |
|---|---|---|
Market Cap | $4.04B | $7.61B |
Sector | Health | Health |
52-Week High | $25.45 | $58.57 |
52-Week Low | $12.30 | $11.34 |
Enterprise Value | $4.10B | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
